GSK Sees Big Opportunity In OTC Diet Aids: Xenical Switch NDA Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm filed an NDA for orlistat 60 mg OTC switch in June, CEO Garnier says during July 28 earnings call. A successful switch bid could depend on GSK’s ability to address self-treatment concerns.